Cancer Biotherapy & Radiopharm is categorized under Periodical Publishers in New Rochelle, NY .
Cancer Biotherapy & Radiopharm was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Periodical Publishers business, which does work in the B2B market, and is classified as a Periodical Publishers, under code number 5111200 by the NAICS.
If you are seeking more information, feel free to contact Mary Liebert, President at the company’s single location by writing to 140 Huguenot St, New Rochelle, New York NY 10801 or by phoning (914) 740-2100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cancer Biotherapy & Radiopharm |
| Contact Person: | Mary Liebert, President |
| Address: | 140 Huguenot St, New Rochelle, New York 10801 |
| Phone Number: | (914) 740-2100 |
| Website Address: | liebertpub.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Periodical Publishers |
| SIC Code: | 2721 |
| NAICS Code: | 5111200 |
| Share This Business: |
Cancer Biotherapy & Radiopharm was started in 0 to provide professional Periodical Publishers under the SIC code 2721 and NAICS code 5111200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Mary Liebert, President for inquiries that concern Cancer Biotherapy & Radiopharm by calling the company number (914) 740-2100, as your correspondence is most welcome. Additionally, the physical location of the single location of Cancer Biotherapy & Radiopharm can be found at the coordinates 40.91326,-73.77897 as well as the street address 140 Huguenot St in New Rochelle, New York 10801.
For its online presence, you may visit Cancer Biotherapy & Radiopharm’s website at liebertpub.com and engage with its social media outlets through on Twitter and on Facebook.